I know what you’re thinking. Didn’t they already do this? Well, yes and no. In the lead up to the release of the Cass Review the UK did call a halt on puberty blockers.
England’s National Health Service has banned the use of puberty blockers for the treatment of gender dysphoria or gender incongruence in transgender minors…
The agency said it made the move after considering an evidence review conducted by England’s National Institute for Health and Care Excellence.
“We have concluded that there is not enough evidence to support the safety or clinical effectiveness of puberty suppressing hormones to make the treatment routinely available at this time,” an NHS spokesperson told ABC News in a statement.
That restriction, announced in March, applied to new prescriptions of puberty blockers for gender care by the National Health Service. However it did not apply to private physicians who…
